Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Postdoctoral Fellow in Cancer Epigenomics at Ontario Cancer Institute - Toronto

    The Ontario Cancer Institute (OCI) at Princess Margaret Hospital - a teaching hospital of the University of Toronto - ranks in the top 5 cancer research centers in the world. Its research activities are concentrated on epigenomics, cancer immunotherapy, cancer stem cells, image-guided therapeutics, patient survivorship, and personalized medicine. The University of Toronto and its affiliated hospital research institutes comprise one of the largest and most productive centers of biomedical research in North America while the City of Toronto is ranked fourth in the Economist’s list of World’s Most Liveable Cities, and second in PriceWaterhouseCooper’s Cities of Opportunity in 2011.
    For more information about the institute: http://www.uhntrainees.ca/

    Computational Biology

    A bioinformatics Postdoctoral Fellow or Research Associate position is available immediately within the group of Daniel D. De Carvalho, Ph.D. Our lab focuses on understanding the mechanisms driving cancer-specific epigenetic alterations, with the ultimate goal of allowing target-specific epigenetic interventions. To achieve this goal, we perform functional genomic screening, combined with systems biology and a variety of genome-wide profiling of epigenetic modifications, using next-generation sequencing (NGS) and microarray technologies. We are specifically seeking individuals with strong computational, bioinformatics, and/or statistical backgrounds to be involved in NGS data analysis. Applicants must be highly motivated and able to communicate effectively in English.

    For more information about our work, prospective applicants are encouraged to refer to the following papers:
    Cancer Cell. 2012 May 25;21(5):655-67 (PMID: 22624715);
    Cell. 2011 Dec 9;147(6):1283-94 (PMID: 22153073);
    PNAS. 2011 Aug 30;108(35):14497-502 (PMID: 21844352);
    PLoS Genet. 2011 Feb 3;7(2):e1001286 (PMID: 21304883);
    Nat Biotechnol. 2010 Oct 13;28(10):1069- 1078 (PMID: 20944599);
    Oncogene. 2011 Jan 13;30(2):223-33 (PMID: 20838376).

    Please send your curriculum vitae and the contact information for 3 references to Daniel D. De Carvalho, Ph.D. ([email protected]).

Latest Articles

Collapse

  • seqadmin
    Strategies for Sequencing Challenging Samples
    by seqadmin


    Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
    03-22-2024, 06:39 AM
  • seqadmin
    Techniques and Challenges in Conservation Genomics
    by seqadmin



    The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.

    Avian Conservation
    Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...
    03-08-2024, 10:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Yesterday, 06:37 PM
0 responses
8 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 06:07 PM
0 responses
8 views
0 likes
Last Post seqadmin  
Started by seqadmin, 03-22-2024, 10:03 AM
0 responses
49 views
0 likes
Last Post seqadmin  
Started by seqadmin, 03-21-2024, 07:32 AM
0 responses
66 views
0 likes
Last Post seqadmin  
Working...
X